MET vs ORGO · P/E 13, rev $38.23B vs rev $81.0M
MetLife Inc (MET) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
MET currently screens at market cap $52.16B and trailing P/E 12.7. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the MET and ORGO stock pages for the full models.
Not investment advice.